Au 31.12.2010
Total number of outstanding shares forming the capital - 4,959,935 ordinary shares under isin FR0000054694 - 1,450,996 preferred shares under ISIN FR0010833251 |
6,410,931 |
Total number of outstanding shares forming the capital with voting rights - 4,959,935 ordinary shares under ISIN FR0000054694 - 0 shares from stock-options under ISIN FR0000054694 |
4,959,935 |
Number of shares with double voting rights | 86,750 |
Total number of gross voting rights | 5,046,685 |
Number of shares without voting rights - 7,000 registered shares - 5 632 actions sous la forme porteur dans le cadre du contrat de liquidité |
- 7,000 - 5,632 |
Total number of exercisable voting rights* | 5,034,053 |
*Real number of voting rights = total number of voting rights – number of shares without voting rights
Download our press releases and other publications on www.naturex.com
Naturex is listed on NYSE Euronext Paris since October 1996 – Compartment B.
Number of shares forming the capital: 6,410,931
ISIN: FR0000054694 (NRX) - Reuters: NATU.PA - Bloomberg: NRX:FP |
About Naturex
Naturex is the world leader in specialty plant-based natural ingredients.
The Group, organized around three strategic markets - Food&Beverage, Nutrition&Health and Personal Care - , manufactures and markets natural ingredients for food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex, whose head office is based in Avignon (France), employs more than 950 persons and benefits from high performance industrial resources through 11 production sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), in Morocco, in the United States, in Brazil and in Australia. Moreover, the Group has a worldwide geographical presence through a dedicated sales network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E, Thailand, Singapore, Japan, China, Australia, the United States, Australia).
Naturex’s sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers customized solutions with the means to meet the requirements of their end consumers.
Its strength lies in its ability to position itself on specific products which constitute niche markets.
Contacts Naturex
Jacques Dikansky President and CEO Tél : +33 (0)4 90 23 96 89 naturex@naturex.com Carole Alexandre Investor Relations Tél : +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Thierry Lambert Vice-President and CFO Tél : +33 (0)4 90 23 96 89 t.lambert@naturex.com |
Contacts Actus
Anne Catherine Bonjour Press Relations Tél : +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Jérôme Fabreguettes-Leib Investor Relations Tél : +33 (0)1 77 35 04 36 jfl@actus.fr |